ArticleACS medicinal chemistry letters2018

Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.

Xianhai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.